Revolutionizing Drug Development With Optical Imaging

This whitepaper explores how cutting-edge bioluminescent and fluorescent optical imaging technologies are transforming drug development. By enhancing the efficiency of preclinical studies, these advancements in imaging are proving instrumental in accelerating timelines, reducing costs, and improving the accuracy of early-stage data.